Good Samaritan Medical Center Brings New Technology and Services to the Newly Redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches

Good Samaritan Medical Center part of the Palm Beach Health Network, has announced a new look and new equipment in the redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches.

The Palm Beach Health Network invested nearly a quarter of a million dollars into the center, bringing a sleek and calm aesthetic look, along with some of the newest high-end technology for patients being treated for their breast health.

“As we continue to change the way we treat breast cancer, it is important we continue to keep up with the latest and newest technology, so the residents of Palm Beach County can benefit from getting the very best treatments for their overall breast health,” said Sheri Montgomery, chief executive officer for Good Samaritan Medical Center. “As we have done for over 100 years, our newly redesigned center will continue to provide amazing quality care to the South Florida community.”

Some of the new additions to the center include:

  • The Genius 3D Mammography™ exam with Hologic Clarity HD – This technology generates images of the breast that are sharper and even more detailed so a cancer can be detected earlier, when it is easier to treat. It also cuts down on unnecessary follow-up appointments by up to 40% compared to 2D imaging alone. It also produces images quicker so less time for the patient to have their breast under compression
  • Affirm Breast Biopsy Guidance System – This system allows doctors to quickly perform 3D breast biopsies on patients and accurately target regions of interest for a breast biopsy assisting in breast cancer detection.
  • Supersonic Mach 40 Ultrasound – The Ultrasound system gives the highest resolution images of patients to enhance diagnostic certainty, regardless of tissue density.

“We feel confident that by offering these new technological capabilities it will ensure greater patient care and confidence for those who come in for their yearly mammograms,” said Dr. Elena Rehl, breast surgeon on staff at Good Samaritan Medical Center. “It is so important not to delay care, especially for your annual mammogram.  If you have been putting it off, we encourage you to make an appointment today.”

The Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches brings together a multi-disciplinary team of cancer specialists and allied health professionals, advanced technology and cancer resources so patients and their families may receive a comprehensive diagnosis, treatment and support services.  Call 561-650-6441 or visit www.goodsamaritanmc.com.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version